• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Anti-influenza activity of Bacillus subtilis probiotic strain

tetano

Editor, Senior Moderator
Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00539-17. doi: 10.1128/AAC.00539-17. [Epub ahead of print]
[h=1]Anti-influenza activity of Bacillus subtilis probiotic strain.[/h] Starosila D[SUP]1[/SUP], Rybalko S[SUP]1[/SUP], Varbanetz L[SUP]2[/SUP], Ivanskaya N[SUP]1[/SUP], Sorokulova I[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Among Bacillus bacteria, B. subtilis is the most productive species of antimicrobial compounds. In this study, we analyzed the activity of probiotic strain B. subtilis 3 against influenza virus. The antiviral effect of this strain has been demonstrated in vitro and in vivo New peptide P18 produced by probiotic strain was isolated, purified, chemically synthesized, and characterized. Cytotoxicity studies demonstrated no toxic effect of P18 on Madin-Darby canine kidney (MDCK) cells, even in the highest tested concentration (100 μg/mL). Complete inhibition of influenza virus in vitro was observed at concentrations 12.5 - 100 μg/mL. Protective effect of P18 in mice was comparable with Tamiflu. Further study will assess the potential of peptide P18 as antiviral compound and as a promising candidate for the development of new antiviral vaccines.
Copyright ? 2017 American Society for Microbiology.


PMID: 28416546 DOI: 10.1128/AAC.00539-17
 
Back
Top Bottom